Venus Remedies - National phase filing completed for 5th PCT

Venus Remedies Ltd has informed that maintaining its pace of IP creation, Venus's IPR Wing has successfully filed for Patent protection for Company's 5th Research Product, "Treatment and Control of severe infections, including Cystic Fibrosis" in 47 countries around the globe where the product is planned to be launched by the Company.

This revolutionary antibiotic, a Fixed Dose Combination, was developed by the Research and Development wing of the Company as a premium solution for multi-resistant strains of bacteria, especially in Cystic Fibrosis patients. The Indian Patent for the same is under process since June 2005 while the National Phase of the PCT application has been completed with the filing of Patent applications in 47 selected countries having good potential market for the product. These include regulated markets like USA, Brazil, entire European Union, Australia, New Zealand and Japan.

The International Regulatory Affairs Department of the Company will be filing dossiers for
Product registration in these countries for market authorizations and the product will be
launched in international market worth USD 500 million, for the first time globally, by the Company.